Calidi Biotherapeutics, Inc. (CLDI)
NYSEAMERICAN: CLDI · Real-Time Price · USD
0.3768
-0.0212 (-5.33%)
At close: May 29, 2025, 4:00 PM
0.3990
+0.0222 (5.89%)
After-hours: May 29, 2025, 8:00 PM EDT
Calidi Biotherapeutics Employees
Calidi Biotherapeutics had 28 employees as of December 31, 2024. The number of employees decreased by 13 or -31.71% compared to the previous year.
Employees
28
Change (1Y)
-13
Growth (1Y)
-31.71%
Revenue / Employee
n/a
Profits / Employee
-$770,536
Market Cap
12.66M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 28 | -13 | -31.71% |
| Dec 31, 2023 | 41 | 3 | 7.89% |
| Dec 31, 2022 | 38 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
| AbbVie | 55,000 |
CLDI News
- 7 days ago - Innovation In Indexing: Why Passive ETFs Matter - ETF Trends
- 4 weeks ago - Calidi Biotherapeutics Reports Inducement Grant Under NYSE American LLC Company Guide Section 711 - GlobeNewsWire
- 5 weeks ago - When Domestic ETF Bias Meets Intentional International Exposure - ETF Trends
- 6 weeks ago - Global X Launches 2 Domestic-Focused ETFs - ETF Trends
- 6 weeks ago - Global X Offers Precise U.S. Equity Exposure with Launch of Domestic Focused Funds - PRNewsWire
- 2 months ago - Calidi Biotherapeutics Announces Closing of $3.9 Million Registered Direct Offering and Concurrent Private Placement - GlobeNewsWire
- 2 months ago - Calidi Biotherapeutics Announces Pricing of $3.9 Million Registered Direct Offering and Concurrent Private Placement - GlobeNewsWire
- 2 months ago - Calidi Biotherapeutics Announces Demonstrated Ability To Deliver Transient Gene Therapy (Payload) To Tumors Using Systemic Platform - GlobeNewsWire